178 related articles for article (PubMed ID: 36474143)
1. Identification of multiplicatively acting modulatory mutational signatures in cancer.
Kičiatovas D; Guo Q; Kailas M; Pesonen H; Corander J; Kaski S; Pitkänen E; Mustonen V
BMC Bioinformatics; 2022 Dec; 23(1):522. PubMed ID: 36474143
[TBL] [Abstract][Full Text] [Related]
2. Patterns and processes of somatic mutations in nine major cancers.
Jia P; Pao W; Zhao Z
BMC Med Genomics; 2014 Feb; 7():11. PubMed ID: 24552141
[TBL] [Abstract][Full Text] [Related]
3. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
Meier B; Volkova NV; Gerstung M; Gartner A
DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
[TBL] [Abstract][Full Text] [Related]
4. Modeling clinical and molecular covariates of mutational process activity in cancer.
Robinson W; Sharan R; Leiserson MDM
Bioinformatics; 2019 Jul; 35(14):i492-i500. PubMed ID: 31510643
[TBL] [Abstract][Full Text] [Related]
5. Regional mutational signature activities in cancer genomes.
Timmons C; Morris Q; Harrigan CF
PLoS Comput Biol; 2022 Dec; 18(12):e1010733. PubMed ID: 36469539
[TBL] [Abstract][Full Text] [Related]
6. Analysis of mutational signatures with yet another package for signature analysis.
Hübschmann D; Jopp-Saile L; Andresen C; Krämer S; Gu Z; Heilig CE; Kreutzfeldt S; Teleanu V; Fröhling S; Eils R; Schlesner M
Genes Chromosomes Cancer; 2021 May; 60(5):314-331. PubMed ID: 33222322
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Mutational Signatures Using the mutSignatures R Library.
Fantini D; Meeks JJ
Methods Mol Biol; 2023; 2684():45-57. PubMed ID: 37410227
[TBL] [Abstract][Full Text] [Related]
8. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
9. MutSignatures: an R package for extraction and analysis of cancer mutational signatures.
Fantini D; Vidimar V; Yu Y; Condello S; Meeks JJ
Sci Rep; 2020 Oct; 10(1):18217. PubMed ID: 33106540
[TBL] [Abstract][Full Text] [Related]
10. The repertoire of mutational signatures in human cancer.
Alexandrov LB; Kim J; Haradhvala NJ; Huang MN; Tian Ng AW; Wu Y; Boot A; Covington KR; Gordenin DA; Bergstrom EN; Islam SMA; Lopez-Bigas N; Klimczak LJ; McPherson JR; Morganella S; Sabarinathan R; Wheeler DA; Mustonen V; ; Getz G; Rozen SG; Stratton MR;
Nature; 2020 Feb; 578(7793):94-101. PubMed ID: 32025018
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of mutational signature software on correlated signatures.
Wu Y; Chua EHZ; Ng AWT; Boot A; Rozen SG
Sci Rep; 2022 Jan; 12(1):390. PubMed ID: 35013428
[TBL] [Abstract][Full Text] [Related]
12. Flexible model-based non-negative matrix factorization with application to mutational signatures.
Laursen R; Maretty L; Hobolth A
Stat Appl Genet Mol Biol; 2024 Jan; 23(1):. PubMed ID: 38753402
[TBL] [Abstract][Full Text] [Related]
13. Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.
Farmanbar A; Firouzi S; Kneller R; Khiabanian H
J Transl Med; 2022 Feb; 20(1):65. PubMed ID: 35109853
[TBL] [Abstract][Full Text] [Related]
14. A framework for mutational signature analysis based on DNA shape parameters.
Karolak A; Levatić J; Supek F
PLoS One; 2022; 17(1):e0262495. PubMed ID: 35015788
[TBL] [Abstract][Full Text] [Related]
15. Model selection and robust inference of mutational signatures using Negative Binomial non-negative matrix factorization.
Pelizzola M; Laursen R; Hobolth A
BMC Bioinformatics; 2023 May; 24(1):187. PubMed ID: 37158829
[TBL] [Abstract][Full Text] [Related]
16. A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependencies.
Degasperi A; Amarante TD; Czarnecki J; Shooter S; Zou X; Glodzik D; Morganella S; Nanda AS; Badja C; Koh G; Momen SE; Georgakopoulos-Soares I; Dias JML; Young J; Memari Y; Davies H; Nik-Zainal S
Nat Cancer; 2020 Feb; 1(2):249-263. PubMed ID: 32118208
[No Abstract] [Full Text] [Related]
17. Mutational signature learning with supervised negative binomial non-negative matrix factorization.
Lyu X; Garret J; Rätsch G; Lehmann KV
Bioinformatics; 2020 Jul; 36(Suppl_1):i154-i160. PubMed ID: 32657388
[TBL] [Abstract][Full Text] [Related]
18. Procarcinogen Activation and Mutational Signatures Model the Initiation of Carcinogenesis in Human Urothelial Tissues In Vitro.
Baker SC; Mason AS; Southgate J
Eur Urol; 2020 Aug; 78(2):143-147. PubMed ID: 32349929
[TBL] [Abstract][Full Text] [Related]
19. SigsPack, a package for cancer mutational signatures.
Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
[TBL] [Abstract][Full Text] [Related]
20. MutVis: Automated framework for analysis and visualization of mutational signatures in pathogenic bacterial strains.
Prasanna A; Niranjan V
Infect Genet Evol; 2021 Jul; 91():104805. PubMed ID: 33689914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
